ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
A study in mice suggests that loosening the reins on the body’s immune system could help repair damage in the brain caused by Alzheimer’s disease. Inhibiting a protein that restrains immune responses cleared out characteristic protein plaques in the animals’ brains and improved their memory (Nat. Med. 2016, DOI: 10.1038/nm.4022). Michal Schwartz of Weizmann Institute of Science and colleagues last year showed that stimulating an immune response in mouse brains reversed symptoms of Alzheimer’s. They concluded that boosting immunity could be a strategy for treating the disease. In the new study, they looked for inspiration from cancer therapies that manipulate so-called immune checkpoint proteins to push the immune system to attack tumors. These signaling proteins encourage or discourage immune cells from springing into action. Schwartz’s team decided to test an antibody that inhibits PD-1, one of the checkpoint proteins. In mice genetically engineered to carry known Alzheimer’s mutations, the antibody led to recruitment of immune cells called macrophages to the brain. The mice later exhibited fewer plaques of amyloid-β—one peptide associated with the disease—and had improved performance in a test of learning and memory.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X